Miata Wallace, PA
Physician Assistant · Lincoln, NENPI 1013656990
Payments from drug & device makers
Across 77 payments — averaging $23.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avadel CNS Pharmaceuticals, LLC$251
- Jazz Pharmaceuticals Inc.$224
- Grifols USA, LLC$207
- Harmony Biosciences LLC$137
- Astellas Pharma US Inc$115
- United Therapeutics Corporation$113
- plus $776 from 17 others
What the payments were for
- Consulting fees$20011%
- Food & beverage$1,45980%
- Education$1659%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avadel CNS Pharmaceuticals, LLC | 5 | $251 |
| Jazz Pharmaceuticals Inc. | 8 | $224 |
| Grifols USA, LLC | 10 | $207 |
| Harmony Biosciences LLC | 2 | $137 |
| Astellas Pharma US Inc | 4 | $115 |
| United Therapeutics Corporation | 4 | $113 |
| Boehringer Ingelheim | 7 | $108 |
| AstraZeneca | 5 | $75 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Sanofi | 4 | $66 |
| Actelion Pharmaceuticals US, Inc. | 4 | $63 |
| Amgen | 3 | $62 |
| Inspire Medical Systems, Inc. | 2 | $52 |
| Regeneron Healthcare Solutions, Inc. | 3 | $45 |
| Baxter Healthcare | 1 | $41 |
| Abiomed | 1 | $38 |
| GSK | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $28 |
| Johnson & Johnson | 2 | $26 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $18 |
| Insmed, Inc. | 1 | $16 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,824 in reported general payments places this provider in the 80th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 167 | $118,187 |
| Dupixent PenDupilumab | 27 | $117,963 |
| NucalaMepolizumab | 16 | $68,497 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 63 | $39,038 |
| YupelriRevefenacin | 22 | $31,918 |
| Breo ElliptaFluticasone/Vilanterol | 71 | $30,946 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 57 | $27,909 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 41 | $27,694 |
| Spiriva RespimatTiotropium Bromide | 24 | $17,961 |
| SymbicortBudesonide/Formoterol Fumarate | 62 | $16,496 |
| DuleraMometasone/Formoterol | 42 | $15,494 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 31 | $13,299 |
| Formoterol Fumarate | 11 | $10,118 |
| Advair HfaFluticasone Propion/Salmeterol | 23 | $9,101 |
| Incruse ElliptaUmeclidinium Bromide | 19 | $7,421 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $32 | $255,150341 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $75 | $57,488134 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $108 | $56,99987 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,127 physician assistant providers in Nebraska.
Other physician assistant in Lincoln
- Laura TvrdyLincoln$13K
- Courtney MaresLincoln$13K
- Jacklynn KmentLincoln$10K
- Bethany LambertLincoln$9K
- Kelsey WerginLincoln$8K
- Makayla DoolittleLincoln$7K
- Christina MeyerLincoln$7K
- Ashley JohnsonLincoln$7K
- Shaun RingLincoln$7K
- Katelyn EspinozaLincoln$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.